Innovation, Research
EG427: treating neurogenic bladder with precision gene therapy
… François Giuliano, Pierre Denys and Alberto Epstein from the Neuromuscular Disability: Physiopathology, … treat urinary disorders of neurological origin. (c)EG427 From guidance to start-up Vector used in gene therapy by … to launch the development of this young pharmaceutical company and recruit its team. “We’re the only company in …
Published on: